CONTENT

This web page had the following on the web page, "A novel target for the treatment of inflammatory diseases." Our analyzers saw that the web site said " Is a virtual Danish biotech company focused on design and development of novel small molecule inhibitors of dipeptidyl peptidase I DPPI; also known as cathepsin C for treatment of inflammatory diseases." The Website also said " Unizyme has developed an oral available candidate drug XPZ-35, which. Has a PK profile that supports a once-daily oral dosing regime. The next step in the XPZ-35 development process is GMP batch production a." The website's header had Dipeptidyl peptidase I as the most important optimized keyword. It is followed by recombinant proteins, therapeutic proteins and enzymes, and his-tag protein purification which isn't as highly ranked as Dipeptidyl peptidase I. The next words unizyme.dk uses is tag removal development. peptidases was included and could not be viewed by search engines.